Found 9 results
Filters: Author is X. Xie  [Clear All Filters]
Y. - Y. Zheng, Xie, X., Ma, Y. - T., Yang, Y. - N., Fu, Z. - Y., Li, X. - M., Liu, F., Yang, S. - J., Ma, X., and Chen, B. - D., S323I polymorphism of the C5L2 gene was not identified in a Chinese population with familial combined hyperlipidemia or with type 2 diabetes, vol. 10, pp. 3256-3266, 2011.
Aouizerat BE, Allayee H, Cantor RM, Davis RC, et al. (1999). A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11. Am. J. Hum. Genet. 65: 397-412. PMid:10417282 Cianflone K (2003). Acylation stimulating protein and triacylglycerol synthesis: potential drug targets? Curr. Pharm. Des. 9: 1397-1410. PMid:12769731 Cianflone K, Xia Z and Chen LY (2003). Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim. Biophys. Acta 1609: 127-143. Cui W, Lapointe M, Gauvreau D, Kalant D, et al. (2009a). Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation. Mol. Immunol. 46: 3207- 3217. PMid:19767107 Cui W, Simaan M, Laporte S, Lodge R, et al. (2009b). C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation. Mol. Immunol. 46: 3086-3098. PMid:19615750 de Lind van Wijngaarden RF, Cianflone K, Gao Y, Leunissen RW, et al. (2010). Cardiovascular and metabolic risk profile and acylation-stimulating protein levels in children with Prader-Willi syndrome and effects of growth hormone treatment. J. Clin. Endocrinol. Metab. 95: 1758-1766. Faraj M, Sniderman AD and Cianflone K (2004). ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. J. Lipid Res. 45: 657-666. PMid:14703506 Huertas-Vazquez A, Aguilar-Salinas C, Lusis AJ, Cantor RM, et al. (2005). Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1. Arterioscler. Thromb. Vasc. Biol. 25: 1985-1991. PMid:15976322 Kalant D, MacLaren R, Cui W, Samanta R, et al. (2005). C5L2 is a functional receptor for acylation-stimulating protein. J. Biol. Chem. 280: 23936-23944. PMid:15833747 MacLaren R, Kalant D and Cianflone K (2007). The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance. Biochem. Cell Biol. 85: 11-21. PMid:17464341 Marcil M, Vu H, Cui W, Dastani Z, et al. (2006). Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemia. Arterioscler. Thromb. Vasc. Biol. 26: 1619-1625. PMid:16627811 Maslowska M, Wang HW and Cianflone K (2005). Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence. Vitam. Horm. 70: 309-332. Paglialunga S, Julien P, Tahiri Y, Cadelis F, et al. (2009). Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels. J. Lipid Res. 50: 1109-1119. PMid:19237736    PMCid:2681393 Saleh J, Al-Khanbashi M, Al-Maarof M, Al-Lawati M, et al. (2009). Acylation-stimulating protein increases and correlates with increased progesterone levels during the luteal phase of the menstrual cycle. Eur. J. Endocrinol. 160: 301-307. PMid:19022911 Xiang SQ, Cianflone K, Kalant D and Sniderman AD (1999). Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase. J. Lipid Res. 40: 1655-1663. PMid:10484612 Xiang X, Ma YT, Fu ZY, Yang YN, et al. (2009). Haplotype analysis of the CYP8A1 gene associated with myocardial infarction. Clin. Appl. Thromb. Hemost. 15: 574-580. PMid:19147528 Xie X, Ma YT, Fu ZY, Yang YN, et al. (2009). Association of polymorphisms of PTGS2 and CYP8A1 with myocardial infarction. Clin. Chem. Lab. Med. 47: 347-352. PMid:19327107 Xie X, Ma YT, Yang YN, Li XM, et al. (2010a). Alcohol consumption and ankle-to-brachial index: results from the Cardiovascular Risk Survey. PLoS One 5: e15181. PMid:21152041    PMCid:2996294 Xie X, Ma YT, Yang YN, Fu ZY, et al. (2010b). Polymorphisms in the SAA1/2 gene are associated with carotid intima media thickness in healthy Han Chinese subjects: the Cardiovascular Risk Survey. PLoS One 5: e13997. PMid:21103356    PMCid:2982816 Yang YN, Wang XL, Ma YT, Xie X, et al. (2010). Association of interaction between smoking and CYP 2C19*3 polymorphism with coronary artery disease in a Uighur population. Clin. Appl. Thromb. Hemost. 16: 579-583. PMid:20460345